Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2026-01-23 @ 1:58 PM
Study NCT ID:
NCT00027560
Status:
COMPLETED
Last Update Posted:
2013-01-07
First Post:
2001-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
Sponsor:
Organization: